Powell-Tuck J, Buckell N A, Lennard-Jones J E
Scand J Gastroenterol. 1977;12(8):971-5. doi: 10.3109/00365527709181359.
A randomized controlled trial has been made of corticotropin (ACTH) 80 units given intramuscularly daily and hydrocortisone 400 mg infused intravenously over 24 hours, in the treatment of in-patients with severe proctocolitis. Seven patients were treated with ACTH and nine with hydrocortisone over an initial seven days. Three patients in the ACTH group and six in the hydrocortisone group improved and were discharged on medical treatment. Four patients treated with ACTH and two with hydrocortisone required urgent colectomy during this admission. Plasma cortisol levels were measured, but there was no correlation between these and the observed therapeutic response. Sideeffects were troublesome in both groups but were more marked in those treated with hydrocortisone. It is concluded that ACTH is not intrinsically superior to hydrocortisone in these doses, in the treatment of severe proctocolitis.
针对重症直肠结肠炎住院患者,开展了一项随机对照试验,比较每日肌肉注射80单位促肾上腺皮质激素(ACTH)与24小时内静脉输注400毫克氢化可的松的治疗效果。最初七天,七名患者接受ACTH治疗,九名患者接受氢化可的松治疗。ACTH组三名患者和氢化可的松组六名患者病情改善,经药物治疗后出院。此次住院期间,ACTH组四名患者和氢化可的松组两名患者需要紧急进行结肠切除术。测量了血浆皮质醇水平,但这些水平与观察到的治疗反应之间没有相关性。两组均出现了令人困扰的副作用,但在接受氢化可的松治疗的患者中更为明显。得出的结论是,在治疗重症直肠结肠炎时,这些剂量的ACTH本质上并不优于氢化可的松。